Copyright © Helsinn Group - Legal Statement

Helsinn adopts a Multi-project Integrated Licensing strategy which focuses on taking valuable pharmaceutical compounds from an early clinical phase to a secure international market ...

Helsinn?s Chemical Operations core activities are the development and manufacturing of Active Pharmaceutical Ingredients (APIs), High Potency Active Ingredients (HPAIs), Advanced ...

Helsinn Chemicals SA, located in Biasca, Southern Switzerland, has over 24 years of experience in custom synthesis dedicated exclusively to the life science industry.

Helsinn Healthcare SA. Helsinn is a Swiss-based Group, focusing on developing and licensing innovative and valuable pharmaceutical compounds up to the highest quality standards.

Privacy policy. Personal data treatment & protection For the treatment and the protection of personal data, The company strictly sticks to the Swiss legislation regarding Data ...

Helsinn Healthcare Streamlines Quality Assurance Globally with Sparta Systems? TrackWise Software. Holmdel, NJ - April 15, 2008 - Sparta Systems, Inc. (Sparta), the maker of ...

LEGAL STATEMENT: This site covers only information relative to Nimesulide - containing pharmaceutical products produced by Helsinn or its authorized ...

Helsinn news - 2002 - Helsinn news - 2002 - Helsinn news - 2002 June 4, 2002 UPDATE ON THE ROLE OF NSAIDs IN PAIN THERAPY: FOCUS ON NIMESULIDE at Helsinn's ...

Media Contact: Giuliana Villa Diane Donlon Helsinn Healthcare Hill & Knowlton 41 91 985 2121 44 207 413 3122 Diego Freri Hill & Knowlton 39 335 641 7881 EUROPEAN MEDICINES ...

Helsinn Chemicals (Ireland) Ltd, Dublin, choose the dataTaker DT600 logger for energy and effluent monitoring, now awarded ISO 14001 DT50 Series 3 data loss during sudden power ...

EvaluatePharma sets a new standard in pharmaceutical and biotechnology company information and analysis. Our service is used by leading pharmaceutical and life science companies ...

Negotiation Skills Training for Sales & Account Managers, Purchasing Managers and Executives. Upgrade skills with negotiating Sales Training.

The webcast of this company's presentation will be available on the date of their presentation, and will be archived for 90 days. Please click here to return to

External weblinks. Manufacturing Chemist is not responsible for the content of external internet sites.

Helsinn Will Present at the 26th Annual J.P. Morgan Healthcare Conference, San Francisco LUGANO, Switzerland, December 18 /PRNewswire/ -- Helsinn Healthcare S.A. today ...

Successful inspection of Helsinn Birex pharmaceuticals Dublin, Ireland by the us food and drug administration

Free Online Library: HELSINN/BIOVITRUM SIGN LICENSE PACT FOR ALOXI MARKETING. by "Worldwide Biotech"; Biotechnology industry Business Cancer Chemotherapy

Free Online Library: MGI PHARMA and HELSINN HEALTHCARE SA Announce Patent Extension for Aloxi(R) Injection. by "Business Wire"; Antimitotic agents Antineoplastic agents Cancer ...

the outcome of helsinn?s active participation in the eular 2006 congress full story... helsinn keeps up its presence at the eular 2006 congress with its anti-inflammatory drugs ...

A Global resource for Healthcare and life science investors and executives. Healthcare Investment Digests deliver speed to knowledge on the companies and technologies shaping ...

Schering-Plough and Helsinn Healthcare SA Announce Licensing Agreement For Palonosetron in Select Global Markets

SOUTH SAN FRANCISCO, Calif., Nov. 16 /PRNewswire/ -- Exelixis, Inc. (Nasdaq: EXEL) today announced that its licensee Helsinn Healthcare SA has discontinued enrollment of new ...

LUGANO, Switzerland, February 11 /PRNewswire/ -- Helsinn Healthcare SA, a Swiss pharmaceutical group, is pleased to announce, ahead of schedule, today's launch in the UK of Aloxi(R ...

Helsinn's New Antiemetic Drug Aloxi Receives Marketing Authorization in Europe LUGANO, SWITZERLAND -- April 4, 2005 -- Helsinn Healthcare SA, a Swiss pharmaceutical group ...

To print: Select File and then Print from your browser's menu-----Title: Helsinn's New Antiemetic ...

Exelixis and Helsinn Sign Agreement for XL119 (becatecarin) SOUTH SAN FRANCISCO, and LUGANO, Switzerland, June 13 /PRNewswire/ --Exelixis, Inc. (Nasdaq:

Successful Inspection of Helsinn Birex Pharmaceuticals Dublin, Ireland by the US Food and Drug Administration. - DUBLIN, Ireland, July 22 /PRNewswire/ -- Helsinn is pleased to ...

Aloxi information from Drugs.com, includes Aloxi side effects, interactions and indications. ... MGI Pharma and Helsinn Announce Submission of Supplemental New Drug Application for ...

A member supported weekly magazine of the American Chemical Society, Chemical And Engineering News covers all the news of the chemical world including science and technology ...